Prescription drug · ANDA
Ursodiol NDC 72603-613
Ursodiol 300 mg/1 · Capsule · Oral · NorthStar Rx LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72603-613-01 | 72603061301 | 100 CAPSULE in 1 BOTTLE (72603-613-01)Marketed from May 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ursodiol
- Generic name (nonproprietary)
- ursodiol
- Active ingredients
- Ursodiol — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- NorthStar Rx LLCNDC labeler code 72603
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214849
- Marketing start
- Listing expires
- Other FDA classes
- Bile Acids and Salts (Chemical structure)
- Identifiers
- Product ID 72603-613_b762c96f-bb2e-4268-b71c-ccda296cb299SPL ID b762c96f-bb2e-4268-b71c-ccda296cb299SPL set ID dd0346e2-5ff3-4208-ad88-d09182684603RxCUI 858747UNII 724L30Y2QR
- Pharmacologic class
- Bile Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472603061301followed by a unit qualifier and the quantityPackage 72603-0613-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ursodiol capsules are indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of ursodiol capsules beyond 24 months is not established. Ursodiol capsules are indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.
Excerpt only. Read the full label for complete information.
About NDC 72603-613
- What is NDC 72603-613?
- 72603-613 is the product NDC for Ursodiol, Ursodiol 300 mg/1 capsule, listed with the FDA by NorthStar Rx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ursodiol.
- What is the active ingredient?
- Ursodiol.
- Who is the labeler?
- NorthStar Rx LLC, NDC labeler code 72603. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ursodiol?
- 43 other product NDCs are listed under this name. See all Ursodiol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ursodiol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-864 | 50268-0864-13 |
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-2633 | 55154-2633-00 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-931 | 42291-0931-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvKARE | 42291-923 | 42291-0923-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-421 | 59651-0421-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2619 | 72162-2619-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | PuraCap Laboratories, LLC | 24658-999 | 24658-0999-10 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-844 | 64380-0844-0464380-0844-0664380-0844-07 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Laurus Labs Limited | 42385-946 | 42385-0946-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-797 | 50268-0797-15 |
Other NDCs under ANDA 214849
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-421 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2619 |